3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Esophageal Neoplasms
9
Melanoma
6
Lung Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Small Cell Lung Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Colorectal Neoplasms
4
Carcinoma, Hepatocellular
4
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Carcinoma, Transitional Cell
2
Unresectable Biliary Tract Cancer
1
Thymus Neoplasms
1
Thymoma
1
Thymic epithelial tumor
1
Small Cell Lung Cancer Extensive Stage
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Pathologic Complete Response
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Nasopharyngeal Neoplasms
1
Muscle-Invasive Bladder Carcinoma
1
Interventions
enzalutamide
1
cemiplimab
1
camrelizumab
1
abiraterone
1
Surgical Instruments
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Bites and Stings
×
Immunotherapy
×
Clear all
NCT05202314
2023-02-21
NACSOC-02
Beijing Chao Yang Hospital
Phase NA
Recruiting
20 enrolled